<€ JTC2018
ERA & nbsp; PerMed will launch in February 2018 the first Joint Transnational Call for Proposals to support translational research projects in the field of Personalized Medicine and to encourage and enable interdisciplinarity, in combining pre-clinical and / or clinical research with bio-informatics & nbsp; components.
ERA & nbsp; PerMed (2017-2022) is a new & nbsp; ERA-Net Cofund Action on Personalized Medicine (PM), supported by 31 partners of 22 countries and cofunded by the European Commission. It aims to align national and regional research strategies and funding activities, promoting excellence, strengthening the competitiveness of European players in & nbsp; PM, and enhancing cooperation with non-EU & nbsp; countries.
ERA & nbsp; PerMed partners have decided to conduct together up to 4 Joint Transnational Calls (JTC) and to launch the first and cofunded & nbsp; JTC & nbsp; in order to fund international high quality research projects in & nbsp; PM.
ERA & nbsp; PerMed is thereby closely linked to & nbsp; ICPerMed and will foster the implementation of the & nbsp; ICPerMed Action Plan & nbsp; by funding transnational research projects in the field of & nbsp; PM.
< Details
- The deadline for pre-proposals & nbsp; is April & nbsp; 10th & nbsp; 2018.
- Consortias invited for the full-proposal stage, will need to submit their proposal on July 5th & nbsp; 2018.
- The available budget for this Call is € 27 million (approx.). & nbsp;
- Read more details at: & nbsp; erapermed.eu
ERA PerMed
- ERA & nbsp; PerMed is a new & nbsp; ERA-Net Cofound, supported by 31 partners of 22 countries and cofunded by the European & nbsp; Commission.
- To align national research strategies, promote excellence, strengthen the competitiveness of European players in & nbsp; PM, and enhance European collaboration with non-EUcountries, 30 funding organizations have agreed to launch the first Joint Transnational Call for collaborative innovative research projects in Personalized Medicine (PM).
- The funding organizations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research & nbsp; proposals.
